BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 17265683)

  • 1. Pyridinium oximes: rationale for their selection as causal antidotes against organophosphate poisonings and current solutions for auto-injectors.
    Stojiljković MP; Jokanović M
    Arh Hig Rada Toksikol; 2006 Dec; 57(4):435-43. PubMed ID: 17265683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.
    Jokanović M; Stojiljković MP
    Eur J Pharmacol; 2006 Dec; 553(1-3):10-7. PubMed ID: 17109842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.
    Antonijevic B; Stojiljkovic MP
    Clin Med Res; 2007 Mar; 5(1):71-82. PubMed ID: 17456837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides.
    Wilhelm CM; Snider TH; Babin MC; Jett DA; Platoff GE; Yeung DT
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):254-65. PubMed ID: 25448441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of obidoxime or HI-6 with atropine against intoxication with some nerve agents in mice.
    Kassa J; Bajgar J
    Acta Medica (Hradec Kralove); 1996; 39(1):27-30. PubMed ID: 9106387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridinium, imidazolium and quinuclidinium compounds: toxicity and antidotal effects against the nerve agents Tabun and Soman.
    Reiner E; Simeon-Rudolf V
    Arh Hig Rada Toksikol; 2006 Jun; 57(2):171-9. PubMed ID: 16832972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of currently used antidotes in tabun-poisoned rats.
    Kassa J; Krejèová G
    Pharmacol Toxicol; 2003 Jun; 92(6):258-64. PubMed ID: 12787257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds.
    Worek F; Widmann R; Knopff O; Szinicz L
    Arch Toxicol; 1998 Mar; 72(4):237-43. PubMed ID: 9587020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative protective effects of HI-6 and MMB-4 against organophosphorous nerve agent poisoning.
    Lundy PM; Hamilton MG; Sawyer TW; Mikler J
    Toxicology; 2011 Jul; 285(3):90-6. PubMed ID: 21524678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the efficacy of HI6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit.
    Koplovitz I; Stewart JR
    Toxicol Lett; 1994 Feb; 70(3):269-79. PubMed ID: 8284794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds.
    Jokanović M; Prostran M
    Curr Med Chem; 2009; 16(17):2177-88. PubMed ID: 19519385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxications.
    Kuca K; Bartosová L; Jun D; Patocka J; Cabal J; Kassa J; Kunesová G
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):75-82. PubMed ID: 16170392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents.
    Kassa J
    J Toxicol Clin Toxicol; 2002; 40(6):803-16. PubMed ID: 12475193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of various oximes against GF (cyclohexyl methylphosphonofluoridate) poisoning in mice.
    Clement JG
    Arch Toxicol; 1992; 66(2):143-4. PubMed ID: 1605730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal choice of acetylcholinesterase reactivators for antidotal treatment of nerve agent intoxication.
    Bajgar J
    Acta Medica (Hradec Kralove); 2010; 53(4):207-11. PubMed ID: 21400978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning.
    Lundy PM; Raveh L; Amitai G
    Toxicol Rev; 2006; 25(4):231-43. PubMed ID: 17288495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of oximes in the treatment of nerve agent poisoning in civilian casualties.
    Marrs TC; Rice P; Vale JA
    Toxicol Rev; 2006; 25(4):297-323. PubMed ID: 17288500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
    Kassa J; Sepsova V; Matouskova L; Horova A; Musilek K
    Toxicol Mech Methods; 2015 Mar; 25(3):229-33. PubMed ID: 25894563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.